Viewing Study NCT00045760


Ignite Creation Date: 2025-12-25 @ 2:17 AM
Ignite Modification Date: 2026-02-23 @ 8:09 PM
Study NCT ID: NCT00045760
Status: COMPLETED
Last Update Posted: 2006-07-20
First Post: 2002-09-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Study of Drotrecogin Alfa (Activated) in a Subpopulation of Adult Patients With Severe Sepsis
Sponsor: Eli Lilly and Company
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 7252, 6669
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators